NEW YORK, Nov. 8 – Sequenom said Thursday it received a $2.2 million grant from the National Institutes of Health to conduct a genome-wide disease association study.

Sequenom of San Diego said it will use its MassArray technology and 100,000 SNP assays to look for genetic variations among people with the blood disease beta-thalassemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.